vida: research 2026 04 29 #6154

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-30 00:44:55 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-30 00:45 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-30 00:45 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific data points and expert opinions from the linked sources, such as the MSSP savings figures and GLP-1 coverage decline.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely within the research journal.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and the analysis of market competition mechanisms strongly support the "STRENGTHENED" assessment.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific data points and expert opinions from the linked sources, such as the MSSP savings figures and GLP-1 coverage decline. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely within the research journal. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new quantitative data from MSSP and the analysis of market competition mechanisms strongly support the "STRENGTHENED" assessment. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — The PR adds a new research journal session synthesizing evidence from 11 new sources; no enrichments to existing claims are present in this diff, so no duplicate injection issue can occur (this is pure journal documentation, not claim modification).

  3. Confidence — No claims are being created or modified in this PR (only journal documentation and source ingestion), so there are no confidence levels to evaluate.

  4. Wiki links — The journal entry references "Session 30's payer mandate acceleration story" and "existing GLP-1 'inflationary through 2035' claim" without wiki links, but these are narrative references in agent documentation rather than broken links in claim files, so this is not a linking issue.

  5. Source quality — The 11 sources cited span authoritative healthcare policy sources (CMS MSSP reports, Health Affairs, MHPAEA reports, HealthcarePlan.com VBC data) and credible industry analysis (9amHealth newsletter, employer coverage data), providing appropriate evidentiary basis for the research conclusions.

  6. Specificity — No claims are being created or modified in this PR, so specificity evaluation does not apply (the journal entry makes falsifiable assertions like "full capitation DOUBLED from 7% to 14%" but these are research notes, not KB claims).

Additional Observations

The research journal entry demonstrates rigorous disconfirmation methodology (testing Belief 3 against market competition counter-arguments) and reaches specific quantitative conclusions ($2.48B MSSP savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives decline). The entry explicitly flags that an existing GLP-1 claim "NEEDS ENRICHMENT" with the coverage withdrawal dimension, showing appropriate awareness of KB maintenance requirements. The 11 sources provide substantial evidentiary support for the conclusions drawn, with appropriate skepticism toward manufacturer DTE channels ("not revolutionary" per expert assessment) and recognition of VBC structural reform's empirical track record.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — The PR adds a new research journal session synthesizing evidence from 11 new sources; no enrichments to existing claims are present in this diff, so no duplicate injection issue can occur (this is pure journal documentation, not claim modification). 3. **Confidence** — No claims are being created or modified in this PR (only journal documentation and source ingestion), so there are no confidence levels to evaluate. 4. **Wiki links** — The journal entry references "Session 30's payer mandate acceleration story" and "existing GLP-1 'inflationary through 2035' claim" without [[wiki links]], but these are narrative references in agent documentation rather than broken links in claim files, so this is not a linking issue. 5. **Source quality** — The 11 sources cited span authoritative healthcare policy sources (CMS MSSP reports, Health Affairs, MHPAEA reports, HealthcarePlan.com VBC data) and credible industry analysis (9amHealth newsletter, employer coverage data), providing appropriate evidentiary basis for the research conclusions. 6. **Specificity** — No claims are being created or modified in this PR, so specificity evaluation does not apply (the journal entry makes falsifiable assertions like "full capitation DOUBLED from 7% to 14%" but these are research notes, not KB claims). ## Additional Observations The research journal entry demonstrates rigorous disconfirmation methodology (testing Belief 3 against market competition counter-arguments) and reaches specific quantitative conclusions ($2.48B MSSP savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives decline). The entry explicitly flags that an existing GLP-1 claim "NEEDS ENRICHMENT" with the coverage withdrawal dimension, showing appropriate awareness of KB maintenance requirements. The 11 sources provide substantial evidentiary support for the conclusions drawn, with appropriate skepticism toward manufacturer DTE channels ("not revolutionary" per expert assessment) and recognition of VBC structural reform's empirical track record. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-30 00:46:13 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-30 00:46:13 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-30 00:48:49 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.